These findings suggest an important role of TRIM16 in the response of these tumor cells to differentiating agents, such as RA, an effective inducer of NB cell differentiation that has been used in the clinic for the treatment of high-risk NB [43]. This evidence concerns the gene TRIM16 and neuroblastoma.